Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy. https://t.co/YHmZMQQKQx
RT @icddr_b: Adjunct therapy using #phenylbutyrate and #vitaminD with standard #tuberculosis treatment shown to improve outcomes: New findi…
Adjunct therapy using #phenylbutyrate and #vitaminD with standard #tuberculosis treatment shown to improve outcomes: New findings w/ @karolinskainst @Haskoli_Islands, https://t.co/PIvdXEGaIo https://t.co/aUrkroqOKa
RT @icddr_b: Use of #phenylbutyrate and #vitaminD as adjunct therapy to standard #tuberculosis treatment promoted favorable immunomodulatio…
Use of #phenylbutyrate and #vitaminD as adjunct therapy to standard #tuberculosis treatment promoted favorable immunomodulation to improve treatment outcomes: @karolinskainst @LUMC_Leiden @Haskoli_Islands study w/ @icddr_b, https://t.co/PIvdXEGaIo https://
RT @icddr_b: New research w/ @karolinskainst on immune responses in the treatment of drug-sensitive pulmonary #tuberculosis w/ #phenylbutyr…
New research w/ @karolinskainst on immune responses in the treatment of drug-sensitive pulmonary #tuberculosis w/ #phenylbutyrate & vitamin D3 as host directed therapy, https://t.co/PIvdXEGaIo w/ @LUMC_Leiden @Haskoli_Islands @uni_iceland https://t.co/
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy. https://t.co/OsRh0n3KF2 https://t.co/qiajS803uJ
Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as ... https://t.co/3r9PCFY5P2